Semaglutide
2 studies
2 studies
- Clinical TrialFull Text
Does semaglutide reduce heart attacks and strokes in people with obesity but no diabetes?
Weekly semaglutide injections reduced heart attacks, strokes, and cardiovascular deaths by 20% in people with obesity and heart disease but no diabetes.
New England Journal of Medicine·2023-11-11·N=17 - Clinical TrialAbstract
Does oral semaglutide reduce heart attacks and strokes in high-risk diabetes patients?
Oral semaglutide reduced major heart and vascular events in people with type 2 diabetes and high cardiovascular risk without increasing serious side effects.
New England Journal of Medicine·2025-03-29